8-KRegulation FDExhibits & Filings

Guardant Health, Inc. 8-K Report, Regulation FD Disclosure (Jan 11, 2021)

Filed January 11, 2021For Securities:GH

Summary

Guardant Health, Inc. (GH) filed an 8-K on January 11, 2021, primarily to disclose investor presentation materials. These materials, attached as Exhibit 99.1, were intended for use in investor conferences and other forums, starting January 11, 2021. The report does not contain new financial statements or material agreements, but rather provides an update on information the company intends to share with the investment community. Investors should note that the information furnished under Item 7.01 is not considered 'filed' for regulatory purposes, meaning it does not trigger certain liabilities under the Securities Exchange Act of 1934, nor is it automatically incorporated into future SEC filings unless specifically referenced. Therefore, while the presentation offers insight into Guardant Health's current messaging, it should be reviewed in conjunction with their regular SEC filings for a complete understanding of the company's financial position and future outlook.

Key Highlights

  • 1Guardant Health filed an 8-K on January 11, 2021, to disclose investor presentation materials.
  • 2The disclosed information is contained in Exhibit 99.1, a presentation dated January 11, 2021.
  • 3The presentation materials are intended for use at investor conferences and other forums.
  • 4The filing is primarily for Regulation FD disclosure purposes.
  • 5Information furnished under Item 7.01 is not deemed 'filed' for Section 18 of the Exchange Act.
  • 6The content is incorporated by reference into the report but not automatically into future filings unless explicitly stated.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose presentation materials that Guardant Health, Inc. intends to use when speaking with investors at conferences and other events. This is done under Regulation FD to ensure broad and fair dissemination of material information.

No, this 8-K filing does not include new financial statements or specific financial results. It primarily serves as a vehicle to share investor presentation slides that contain information the company plans to communicate to the investment community.

Information furnished under Item 7.01 is generally not subject to the same liability provisions as information that is 'filed' with the SEC. This means it won't automatically be incorporated by reference into the company's future SEC filings (like 10-Ks or 10-Qs) unless explicitly stated, and it doesn't carry the same legal implications as formally filed documents.

The content of the presentation is included as Exhibit 99.1 to this 8-K filing. Investors can access this exhibit through the SEC's EDGAR database or Guardant Health's investor relations website to review the information being presented.